Outcome of breast-conserving therapy in the Tokyo women’s medical university breast cancer society experience

[1]  S. Singletary.  Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. , 2002, American journal of surgery.

[2]  Umberto Veronesi,et al.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. , 2002, The New England journal of medicine.

[3]  B. E. F. Isher,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002 .

[4]  T. Nakajima,et al.  Breast-conserving surgery following radiation therapy of 50 Gy in stages I and II carcinoma of the breast: the experience at one institute in Japan. , 2002, Oncology reports.

[5]  T. Nose,et al.  Long-term results of breast conserving surgery for stages I and II breast cancer: Experiences at Osaka Medical Center for cancer and cardiovascular diseases , 2002, Breast cancer.

[6]  I. Barillot,et al.  Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. , 2001, The New England journal of medicine.

[7]  T. Kodaira,et al.  Aichi Cancer Center 10-year experience with conservative breast treatment of early breast cancer: retrospective analysis regarding failure patterns and factors influencing local control. , 2001, International journal of radiation oncology, biology, physics.

[8]  M. Hiraoka,et al.  Results of Breast-Conserving Therapy for Early Stage Breast Cancer: Kyoto University Experiences , 2000, American journal of clinical oncology.

[9]  Richard Sylvester,et al.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. , 2000, Journal of the National Cancer Institute.

[10]  L Collette,et al.  The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  S J Schnitt,et al.  Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  L. Tabár,et al.  10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  D. Schultz,et al.  Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience. , 1999, International journal of radiation oncology, biology, physics.

[14]  D. Wazer,et al.  Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation. , 1999, Radiation oncology investigations.

[15]  T. Kajiwara.  Breast-Conserving therapy: Experience of the breast cancer research group of Tokyo women’s medical college , 1997, Breast cancer.

[16]  P. Romestaing,et al.  Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Noguchi,et al.  Recent progress in breast conserving therapy: From experiences in Japan , 1996, Breast cancer.

[18]  T. Whelan,et al.  Randomized Clinical Trial of Breast Irradiation Following Lumpectomy and Axillary Dissection for Node-Negative Breast Cancer: an Update , 1996 .

[19]  David C. Smith,et al.  Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial , 1996, The Lancet.

[20]  J. Gazet,et al.  The importance of the resection margin in conservative surgery for breast cancer. , 1996, European Journal of Surgical Oncology.

[21]  S. Jeffrey,et al.  The importance of the lumpectomy surgical margin status in long term results of breast conservation , 1995, Cancer.

[22]  Jacques Bernier,et al.  Late effects toxicity scoring: the SOMA scale , 1995 .

[23]  P. Rubin,et al.  EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  P. Rubin,et al.  RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system. , 1995, International journal of radiation oncology, biology, physics.

[25]  S J Schnitt,et al.  The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast‐conserving surgery and radiation therapy , 1994, Cancer.

[26]  Allan Tucker,et al.  Local Failure and Margin Status in Early‐Stage Breast Carcinoma Treated with Conservation Surgery and Radiation Therapy , 1993, Annals of surgery.

[27]  S Hellman,et al.  Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. , 1979, International journal of radiation oncology, biology, physics.